-
Je něco špatně v tomto záznamu ?
Understanding the Acid-Base Response to Respiratory Derangements: Finding, and Clinically Applying, the In Vivo Base Excess
MLA. Heldeweg, K. Berend, P. Schober, F. Duška
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2019
PubMed Central
od 2019
ROAD: Directory of Open Access Scholarly Resources
od 2019
- MeSH
- acidobazická rovnováha * fyziologie MeSH
- dospělí MeSH
- hyperkapnie patofyziologie metabolismus MeSH
- koncentrace vodíkových iontů MeSH
- lidé MeSH
- oxid uhličitý * metabolismus MeSH
- poruchy acidobazické rovnováhy patofyziologie metabolismus MeSH
- psi MeSH
- umělé dýchání MeSH
- zvířata MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- psi MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVES: To evaluate the base excess response during acute in vivo carbon dioxide changes. DESIGN: Secondary analysis of individual participant data from experimental studies. SETTING: Three experimental studies investigating the effect of acute in vivo respiratory derangements on acid-base variables. SUBJECTS: Eighty-nine (canine and human) carbon dioxide exposures. INTERVENTIONS: Arterial carbon dioxide titration through environmental chambers or mechanical ventilation. MEASUREMENTS AND MAIN RESULTS: For each subject, base excess was calculated using bicarbonate and pH using a fixed buffer power of 16.2. Analyses were performed using linear regression with arterial dioxide (predictor), base excess (outcome), and studies (interaction term). All studies show different baselines and slopes for base excess across carbon dioxide titrations methods. Individual subjects show substantial, and potentially clinically relevant, variations in base excess response across the hypercapnic range. Using a mathematical simulation of 10,000 buffer power coefficients we determined that a coefficient of 12.1 (95% CI, 9.1-15.1) instead of 16.2 facilitates a more conceptually appropriate in vivo base excess equation for general clinical application. CONCLUSIONS: In vivo changes in carbon dioxide leads to changes in base excess that may be clinically relevant for individual patients. A buffer power coefficient of 16.2 may not be appropriate in vivo and needs external validation in a range of clinical settings.
Department of Anesthesiology Amsterdam University Medical Centers Amsterdam The Netherlands
Department of Internal Medicine Curaçao Medical Center Willemstad Curaçao
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003021
- 003
- CZ-PrNML
- 005
- 20250206104017.0
- 007
- ta
- 008
- 250121s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/CCE.0000000000001191 $2 doi
- 035 __
- $a (PubMed)39691548
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Heldeweg, Micah L A $u Department of Anesthesiology, Amsterdam University Medical Centers, Amsterdam, The Netherlands $u Department of Anaesthesia and Intensive Care Medicine, The Third Faculty of Medicine, Charles University and FNKV University Hospital, Prague, Czech Republic $1 https://orcid.org/0000000174208486
- 245 10
- $a Understanding the Acid-Base Response to Respiratory Derangements: Finding, and Clinically Applying, the In Vivo Base Excess / $c MLA. Heldeweg, K. Berend, P. Schober, F. Duška
- 520 9_
- $a OBJECTIVES: To evaluate the base excess response during acute in vivo carbon dioxide changes. DESIGN: Secondary analysis of individual participant data from experimental studies. SETTING: Three experimental studies investigating the effect of acute in vivo respiratory derangements on acid-base variables. SUBJECTS: Eighty-nine (canine and human) carbon dioxide exposures. INTERVENTIONS: Arterial carbon dioxide titration through environmental chambers or mechanical ventilation. MEASUREMENTS AND MAIN RESULTS: For each subject, base excess was calculated using bicarbonate and pH using a fixed buffer power of 16.2. Analyses were performed using linear regression with arterial dioxide (predictor), base excess (outcome), and studies (interaction term). All studies show different baselines and slopes for base excess across carbon dioxide titrations methods. Individual subjects show substantial, and potentially clinically relevant, variations in base excess response across the hypercapnic range. Using a mathematical simulation of 10,000 buffer power coefficients we determined that a coefficient of 12.1 (95% CI, 9.1-15.1) instead of 16.2 facilitates a more conceptually appropriate in vivo base excess equation for general clinical application. CONCLUSIONS: In vivo changes in carbon dioxide leads to changes in base excess that may be clinically relevant for individual patients. A buffer power coefficient of 16.2 may not be appropriate in vivo and needs external validation in a range of clinical settings.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a oxid uhličitý $x metabolismus $7 D002245
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a acidobazická rovnováha $x fyziologie $7 D000136
- 650 _2
- $a psi $7 D004285
- 650 _2
- $a poruchy acidobazické rovnováhy $x patofyziologie $x metabolismus $7 D000137
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a hyperkapnie $x patofyziologie $x metabolismus $7 D006935
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a umělé dýchání $7 D012121
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Berend, Kenrick $u Department of Internal Medicine, Curaçao Medical Center, Willemstad, Curaçao
- 700 1_
- $a Schober, Patrick $u Department of Anesthesiology, Amsterdam University Medical Centers, Amsterdam, The Netherlands
- 700 1_
- $a Duška, František $u Department of Anaesthesia and Intensive Care Medicine, The Third Faculty of Medicine, Charles University and FNKV University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00203269 $t Critical care explorations $x 2639-8028 $g Roč. 6, č. 12 (2024), s. e1191
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39691548 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104013 $b ABA008
- 999 __
- $a ok $b bmc $g 2263046 $s 1239028
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 6 $c 12 $d e1191 $e 20241216 $i 2639-8028 $m Critical care explorations $n Crit Care Explor $x MED00203269
- LZP __
- $a Pubmed-20250121